Phase IIa, Randomized, Double Blinded, Placebo Controlled, Dose Finding Study for TLC599 in OA Patients
Clinical trial NCT03005873 · COMPLETED
Trial details
- NCT number
- NCT03005873
- Sponsor
- Taiwan Liposome Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-16
- Primary completion
- 2018-07-04
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.